Month: September 2026

FOR IMMEDIATE RELEASE

NOT FOR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”)) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT. 

Azerion publishes bond prospectus and applies for admission to trading of its bonds on Nasdaq Stockholm 

 

Amsterdam 21 September 2026 – Azerion Group N.V. (the “Company” or “Azerion“) has on 2 October 2025, following the settlement of the Bond Issue, successfully placed a senior secured callable bond issue (the “Bond Issue” or the “Bonds“) in an amount of EUR 225 million under a framework of EUR 350 million with ISIN NO0013660357 (the “Bonds“). The Bonds carry floating rate interest of 3m EURIBOR plus a margin of 5.5 per cent. and have a tenor of four (4) years. 

The Dutch Authority for the Financial Markets (Autoriteit Financiële Markten (the “AFM“)) has on 21 September 2026 approved the prospectus in relation to the admission to trading of the Bonds (the “Prospectus“). The approval of the Prospectus has been notified to the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The Prospectus will be available on the AFM’s website (https://www.afm.nl/en/sector/registers/meldingenregisters/goedgekeurde-prospectussen) and, together with a Swedish translation of the summary of the Prospectus, on the Company’s website (https://www.azerion.com/reports/.

The Company will apply for listing of the Bonds on the Corporate Bond List of Nasdaq Stockholm. The are Bonds expected to be admitted to trading at Nasdaq Stockholm on or about 28 September 2026.

 

For further information, please contact:

Contact: 

ir@azerion.com 

Media 

press@azerion.com 

 

About Azerion 

Founded in 2014, Azerion (EURONEXT: AZRN) is one of Europe’s largest digital advertising and entertainment media platforms. Azerion brings global scaled audiences to advertisers in an easy and cost-effective way, delivered through our proprietary technology, in a safe, engaging, and high quality environment, utilising our strategic portfolio of owned and operated content with entertainment and other digital publishing partners.

Having its roots in Europe and with its headquarters in Amsterdam, Azerion has commercial teams based in over 25 cities around the world to closely support our clients and partners to find and execute creative ways to make a real impact through advertising. 

For more information visit: www.azerion.com 

This communication does not constitute an offer to sell, or a solicitation of an offer to buy, any securities or any other financial instruments.

 

Disclaimer

REGULATORY

This announcement is released by the Company and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (“MAR”), encompassing information relating to the issuance and future listing of the Bonds and redemption of the Bonds described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this document is released, on behalf of the Company by the contact team set out above, at 18:00 CEST on 21 September 2026.

This communication does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any Bonds or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with or act as an inducement to enter into, any contract or commitment whatsoever.

In particular, this communication does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, or form part of any offer, invitation or solicitation to purchase, securities to any person located or resident in the United States or to any U.S. Person (as defined in Regulation S under the U.S. Securities Act). The securities referred to herein have not been, and will not be, registered pursuant to U.S. Securities Act or any securities laws in any state or other jurisdiction in the United States and may not be offered, sold, accepted, exercised, re-sold, renounced, transferred or delivered, whether directly or indirectly, in the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act. No public offering of securities is being, has been, or will be made in the United States.

This communication is made accessible on the basis that any offers of securities referred to herein in any Member State of the EEA will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of such securities. The Bonds have, with respect to persons in Member States of EEA, only been offered to persons who are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Regulation and Section 1:1 of the Dutch Financial Supervision Act. The expression “Prospectus Regulation” means Regulation No. 1129/2017.

In the United Kingdom, the material is made accessible on the basis that any offers of securities referred to herein will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement to publish a prospectus for offers of such securities. The Bonds have, with respect to persons in the United Kingdom, only been offered to persons who are qualified investors within the meaning of Article 2(1)(e) of the UK Prospectus Regulation. The expression “UK Prospectus Regulation” means Regulation (EU) 2017/1129 as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018.

The release, publication or distribution of the material may be restricted by law and persons in such jurisdictions in which a release, publication or distribution of the material should therefore inform themselves about, and observe, any such restrictions.

This press release may include projections and other “forward-looking” statements within the meaning of applicable securities laws. Any such projections or statements reflect the current views of the Company about future events and financial performance. No assurances can be given that such events or performance will occur as projected and actual results may differ materially from these projections.

 

Attachment

• Press Release – September 21 2026 Azerion publishes bond prospectus

Press release – Paris, September 21, 2026, at 6:00 PM CEST

Danone successfully issues a triple-tranche bond totaling €1.5 billion

        
Danone announces that it has today launched a triple-tranche bond offering with a total amount of €1.5 billion, comprising:

• a €500 million tranche of 18-month notes, carrying a floating coupon of 3-month Euribor +0.30%;
• a €500 million tranche of 5-year notes, carrying a 4.0910 % coupon;
• a €500 million tranche of 9-year notes, carrying a 4.4180 % coupon.

In line with the company’s active liquidity management, this issue enables Danone to enhance its funding flexibility while extending the maturity of its debt.

The settlement is expected to take place on September 28^th, 2026, and the bonds will be listed on Euronext Paris.

The bond issue was widely subscribed by a diversified investor base, confirming the high confidence in Danone’s business model and credit profile.

Danone is rated BBB+, stable outlook, by Standard & Poor’s and Baa1, stable outlook, by Moody’s.

The prospectus containing the terms and conditions of the notes will be available on Danone’s website at the following address: Debt & Rating | Danone Group

About Danone (www.danone.com) 

Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices while committing to achieve measurable nutritional, social, societal and environmental impact. Danone has defined its Renew strategy to restore growth, competitiveness, and value creation for the long-term. With c.90,000 employees, and products sold in over 120 markets, Danone generated €27.3 billion in sales in 2025. Danone’s portfolio includes leading international brands (Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, among others) as well as strong local and regional brands (including AQUA, Blédina, Bonafont, Cow & Gate, Mizone, Oikos and Silk). Listed on Euronext Paris and present on the OTCQX platform via an ADR (American Depositary Receipt) program, Danone is a component stock of leading sustainability indexes including the ones managed by Moody’s and Sustainalytics, as well as MSCI ESG Indexes, FTSE4Good Index Series, Bloomberg Gender Equality Index, and Access to Nutrition Index. Danone achieved B Corp^TM certification at global level in 2025.

o o O o o

FORWARD-LOOKING STATEMENTS

This press release contains certain forward-looking statements concerning Danone that are subject to risks and uncertainties. Generally, you can identify these forward-looking statements by forward-looking words, such as “estimate”, “expect”, “anticipate”, “project”, “plan”, “intend”, “objective”, “believe”, “forecast”, “guidance”, “foresee”, “likely”, “may”, “should”, “goal”, “target”, “might”, “will”, “could”, “predict”, “continue”, “convinced” and “confident,” the negative or plural of these words and other comparable terminology or by using future dates. Forward-looking statements in this press release include but are not limited to predictions of future activities, operations, direction, performance and results of Danone.

These forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward-looking statements. For a detailed description of risks and uncertainties, please refer to the “Risk Factor” section of Danone’s Universal Registration Document (the current version of which is available at www.danone.com).

Subject to regulatory requirements, Danone does not undertake to publicly update or revise any of these forward-looking statements. This document does not constitute an offer to sell or a solicitation of an offer to buy Danone securities

        

Attachment

• prdanone210926

Press Release 21 September 2026

Signing of a new €700 million revolving credit facility maturing in 2031

Paris, 21 September 2026: following the success of its €500 million senior bonds offering completed on 8 September, Clariane (CLARI.PA – ISIN FR0010386334) announces today the signing of an unsecured and unguaranteed €700 million revolving credit facility, which replaces its existing syndicated revolving credit facility.

This new revolving credit facility has a five-year maturity and includes an accordion option allowing the facility amount to be increased up to €900 million. The credit facility may be used to finance Clariane’s general purposes, including capital expenditure and the refinancing of the Group’s existing financial indebtedness, excluding hybrid debt.

Utilisations under this new revolving credit facility bear interest at a floating rate equal to EURIBOR plus a margin between 1.75% and 3.50%. The applicable margin will be determined based on the group’s total net leverage ratio¹ (being the ratio of the group’s consolidated net debt to the group’s consolidated EBITDA, excluding IFRS 16 liabilities), with a complementary ESG-linked margin adjustment mechanism (margin reduction or increase events) of up to 6 basis points per annum, based on performance against three agreed key performance indicators².

The financial covenant under this new revolving credit facility is limited to the total net leverage ratio of the group, tested semi-annually, which must not exceed 7.00x until June 2027³, with a progressive step-down to 6.75x (in December 2027), 6.50x (in June 2028), 6.25x (in December 2028) and 6.00x from June 2029 onwards. No liquidity maintenance covenant applies under this new revolving credit facility.

The revolving credit facility also contains customary distribution restrictions, including a limitation on annual dividend distributions to 7% of Clariane’s market capitalisation, subject to the consolidated net leverage ratio of the group not exceeding 4.5x.

---

1 As per the same “Wholeco” leverage definition as set out in the existing financing documentation.
2 The ESG key performance indicators provided for in the new revolving credit facility are: the number of employees enrolled in a qualifying training program (KPI 1), the lost-time injury frequency rate (KPI 2), the percentage of facilities certified ISO 9001 (KPI 3).
3   At 30 June 2026, “Wholeco” leverage stood at 4.9x. Pro forma for the redemption of the ODIRNANE, Wholeco leverage would have stood at 5.4x

Attachment

• PR_Clariane_New syndicated RCF €700m_FV

CAMBRIDGE, Mass., Sept. 21, 2026 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune diseases and cancer, today announced that Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., M.B.A., Chief Medical Officer, will participate in a fireside chat at the Stifel 2026 Virtual Immunology and Inflammation Forum on Thursday, September 24, 2026, at 1:30 p.m. ET.

A webcast of the fireside chat will be available under the Events and Presentations section of the Company’s investor relations website at https://investors.cullinantherapeutics.com/events.

About Cullinan Therapeutics

Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company developing potential first- or best-in-class, disease-modifying T cell engagers for autoimmune diseases and cancer. Cullinan pursues promising therapeutic targets while leveraging core expertise in T cell engagers, which are established in oncology and are now advancing into autoimmune diseases. With a clinical-stage pipeline built on a rigorous scientific approach and purposeful innovation, Cullinan is advancing its mission to deliver new standards of care for patients. Learn more about Cullinan at https://cullinantherapeutics.com/, and follow Cullinan on LinkedIn and X.

Contacts:

Investors
Nick Smith
+1 401.241.3516
Nsmith@cullinantx.com

Media
Rose Weldon
+1 215.801.7644
Rweldon@cullinantx.com

Disclosure of transactions in own shares

Paris, France (September 21, 2026 – 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026, EssilorLuxottica declares that on September 18, 2026, the following share buybacks were carried out:

Name of the issuer	Identity code of the issuer	Day of the transaction	Identity code of the financial instrument	Total daily volume (in number of shares)	Daily weighted average purchase price of the shares (€) *	Market (MIC Code)
ESSILORLUXOTTICA SA	549300M3VH1A3ER1TB49	18/09/2026	FR0000121667	188,650	139.3060	XPAR
ESSILORLUXOTTICA SA	549300M3VH1A3ER1TB49	18/09/2026	FR0000121667	74,150	139.2841	CEUX
ESSILORLUXOTTICA SA	549300M3VH1A3ER1TB49	18/09/2026	FR0000121667	9,825	139.2234	TQEX
ESSILORLUXOTTICA SA	549300M3VH1A3ER1TB49	18/09/2026	FR0000121667	14,375	139.2167	AQEU
			TOTAL	287,000	139.2931

* Rounded to four decimal places

Attachment

• DOWNLOAD THE PRESS RELEASE

Share buyback program

Aggregated disclosure of transactions in own shares
carried out from September 14 to September 18, 2026

 

Paris, September 21, 2026,

Pursuant to the authorization granted by the Combined Shareholders’ Meeting held on April 29, 2026, to operate on its shares and in accordance with the regulations relating to share buybacks, Lectra SA (LEI: 9695000KWQEBUDT6IO19) announces below the transactions in its own shares (LSS – FR0000065484) carried out from September 14 to September 18, 2026:

Issuer Name	Transaction Date	Financial Instrument Identifier Code	Total Daily Volume (number of shares)	Daily Volume Weighted Average Acquisition Price (€)	Market (MIC Code)
LECTRA	09/14/2026	FR0000065484	3,108	21.3363	CEUX
LECTRA	09/14/2026	FR0000065484	4,688	21.3051	XPAR
LECTRA	09/14/2026	FR0000065484	819	21.3261	AQEU
LECTRA	09/14/2026	FR0000065484	437	21.3405	TQEX
LECTRA	09/15/2026	FR0000065484	815	21.5204	AQEU
LECTRA	09/15/2026	FR0000065484	4,916	21.5350	XPAR
LECTRA	09/15/2026	FR0000065484	3,241	21.5095	CEUX
LECTRA	09/15/2026	FR0000065484	435	21.5187	TQEX
LECTRA	09/16/2026	FR0000065484	5,041	20.8555	XPAR
LECTRA	09/16/2026	FR0000065484	3,184	20.8347	CEUX
LECTRA	09/16/2026	FR0000065484	780	20.8408	AQEU
LECTRA	09/16/2026	FR0000065484	444	20.8079	TQEX
LECTRA	09/17/2026	FR0000065484	5,055	20.9568	XPAR
LECTRA	09/17/2026	FR0000065484	3,183	20.9721	CEUX
LECTRA	09/17/2026	FR0000065484	781	20.9580	AQEU
LECTRA	09/17/2026	FR0000065484	434	20.9877	TQEX
LECTRA	09/18/2026	FR0000065484	5,079	20.6054	XPAR
LECTRA	09/18/2026	FR0000065484	3,243	20.6108	CEUX
LECTRA	09/18/2026	FR0000065484	814	20.5836	AQEU
LECTRA	09/18/2026	FR0000065484	441	20.5771	TQEX
		TOTAL	46,938	21.0473

About Lectra Lectra sparks customer transformation.   The Group offers solutions that combine software, cutting equipment, data, and services, leveraging advanced technologies, particularly agentic artificial intelligence. By blending deep sector expertise with industrial intelligence, Lectra helps players in the fashion, automotive, and furniture industries rethink their operations.   In fashion, Lectra supports product development, manufacturing, and marketing, while strengthening collaboration and product traceability. In automotive and furniture, the Group brings its know-how to optimize production processes. Founded in 1973, the Group is present in more than one hundred countries. Lectra’s 2,800 employees are driven by three core values: being open-minded thinkers, trusted partners and passionate innovators. They all share the same commitment to sustainability, which is one of the pillars of Lectra’s strategy to ensure its sustainable growth and that of its customers.   Listed on Euronext, Lectra reported revenues of €507 million in 2025, including €89 million in SaaS revenues.   For more information, visit lectra.com.

Lectra – Registered address: 16–18, rue Chalgrin • 75016 Paris • France
Tel. +33 (0)1 53 64 42 00 – lectra.com
A French Société Anonyme with share capital of €38,063,263. RCS Paris 300 702 305

Attachment

• LECTRA: Share buyback program – Aggregated disclosure of transactions in own shares carried out from September 14 to September 18, 2026

Status update on the project to adapt and strengthen
the Casino Group financial structure – Quatrim bonds

Paris, 21 September 2026

Further to its press release of 7 August reporting the discussions initiated by the Group with the Quatrim bondholders in connection with its plan to adapt and strengthen its financial structure, the Group today announces that it has reached an agreement in principle with a group of Quatrim bondholders representing approximately 35% of the Quatrim debt.

The principal terms of the agreement are as follows:

• One-year extension of the maturity from January 2028 to January 2029; 
• Release of the guarantee granted by Ségisor in respect of the Quatrim bonds;
• Repayment of €10m at closing;
• The Monoprix guarantee is reduced by €10m following the Day-1 redemption and extended by one year to January 2029; and
• The deal includes Extension and Contingent Extension Fees, in addition to consent fees to consenting noteholders 

Further details of the agreement are set out in the presentation published today on the Casino Group website (link).

Binding documentation is expected to be executed in the coming weeks, ahead of a vote of the classes of affected parties in connection with the amendment of the Casino group companies’ plans.

***

 ANALYSTS AND INVESTORS CONTACTS

Charlotte IZABEL – cizabel@groupe-casino.fr – Tel: +33 (0)6 89 19 88 33

IR_Casino@groupe-casino.fr – Tel: +33 (0)1 53 65 24 17

PRESS CONTACTS

Casino Group – Communications Department

Stéphanie ABADIE – sabadie@groupe-casino.fr – Tel: +33 (0)6 26 27 37 05

directiondelacommunication@groupe-casino.fr – Tel: + 33(0) 1 53 65 24 29

Attachment

• 2026-09-21 – PR – Casino Communication

Press Release
Availability of or Access to Information Relating to the
Annual Ordinary and Extraordinary General Meeting of October 19, 2026

Reims, October 19^th 2026

The MAISON POMMERY & ASSOCIES Group informs its shareholders that its Combined Annual Ordinary and Extraordinary General Meeting will be held on Monday, October 19, 2026, at 3 p.m., at Domaine Pommery in Reims (51100).

The notice of meeting including the agenda and the text of the draft resolutions to be submitted to the vote of the shareholders was published in the Bulletin des Annonces Légales Obligatoires (BALO) n° 109 on september 11, 2026 and in the “Preparatory Documents”, posted on the Company’s website at the following address: https://www.maisonpommery.com/en/annual-general-meeting/.

The modalities of participation and voting at this meeting are set out in the Notice of Meeting as well as in the “Preparatory Documents”.

The preparatory documents and information relating to this meeting are available to shareholders and can be consulted on the Company’s website at https://www.maisonpommery.com/en/annual-general-meeting/, in the “Press Releases and Regulated Information” section and on the page dedicated to the General Meeting https://www.maisonpommery.com/en/annual-general-meeting/, in accordance with the applicable legal and regulatory provisions.

Confirmation of outlook:
In accordance with its financial communication dated March 30, 2026, the Group confirms its outlook for growth in recurring operating margin for the 2026 financial year.

Maison Pommery & Associés is a major player in the Champagne sector. The Group controls the entire value chain, from vine cultivation to wine production and marketing. The Group also has a presence in three other wine regions (Provence, Camargue, and Douro). It is strongly committed to promoting terroirs, sustainable viticulture, and environmental preservation.
Maison Pommery & Associés is listed on Euronext Paris and Brussels.
(Code “POMRY” (Paris & Bruxelles); ISIN code: FR0000062796).

 Contacts:

Maison Pommery & Associés:	Press:
Franck Delval, Directeur Financier +33 3 26 61 62 34 comfi@maisonpommery.fr	Laurent Poinsot +33 1 53 70 74 77 lpoinsot@image7.fr	Caroline Simon +33 1 53 70 74 65 caroline.simon@image7.fr

Attachments

• MPA – Mise à disposition_DocAG19102026UK
• MPA – Mise à disposition_DocAG19102026UK

Banco Comercial Português, S.A. informs that Morningstar DBRS has upgraded its issuer rating to “A”

Attachment

• 2026 09 21 Upgrade da DBRS EN_v1